meglumine has been researched along with Angiomyolipoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atwell, TD; Carter, RE; Kawashima, A; Leibovich, BC; Sasiwimonphan, K; Takahashi, N | 1 |
| Bolinger, L; Mitchell, DG; Outwater, EK; Siegelman, ES; Stolpen, AH | 1 |
2 other study(ies) available for meglumine and Angiomyolipoma
| Article | Year |
|---|---|
Small (<4 cm) renal mass: differentiation of angiomyolipoma without visible fat from renal cell carcinoma utilizing MR imaging.
Topics: Angiomyolipoma; Carcinoma, Renal Cell; Contrast Media; Diagnosis, Differential; Female; Humans; Imaging, Three-Dimensional; Kidney Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Statistics, Nonparametric | 2012 |
Fatty tissue on opposed-phase MR images: paradoxical suppression of signal intensity by paramagnetic contrast agents.
Topics: Adipose Tissue; Angiomyolipoma; Contrast Media; Drug Combinations; Fatty Liver; Gadolinium DTPA; Hemangioma; Humans; Image Enhancement; Kidney Neoplasms; Magnetic Resonance Imaging; Meglumine; Melanoma; Organometallic Compounds; Pentetic Acid; Phantoms, Imaging; Spinal Neoplasms | 1996 |